This suggests the possibility of localized autoantibody production in synovial tissues of RA and is supported by results from the same study demonstrating that MAA-modified proteins co-localize with CD19+ and CD27+ B cells in synovium derived from RA patients (22). The gene discussed is CD19; the disease is rheumatoid arthritis.